
16.75 Delayed Data As of May 30 | ![]() Today’s Change | 13.48 Today|||52-Week Range 28.42 | -4.20% Year-to-Date |
Pfizer's (PFE) RSV Vaccine for Infants Gets FDA Panel Vote May 19 / Zacks.com - Paid Partner Content |
Previous close | 16.91 |
Today’s open | 16.69 |
Day’s range | 16.69 - 16.75 |
Volume | 14,012 |
Average volume (3 months) | 2,424 |
Market cap | $69.2B |
Earnings growth (last year) | +203.68% |
Earnings growth (this year) | -- |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -23.01% |
P/E ratio | -- |
Price/Sales | 1.96 |
Price/Book | 5.35 |
Next reporting date | -- |
EPS forecast (this quarter) | -- |
Annual revenue (last year) | $36.1B |
Annual profit (last year) | $18.4B |
Net profit margin | 15.21% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Middlesex, Greater London |